Risk factors for paradoxical response during adequate tuberculosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005
Risk factors for relapses of tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 345s Year: 2003
Risk factors for extrapulmonar tuberculosis Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
Risk factors of hepatotoxicity during tuberculosis treatment and management Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008
Success of re-treatment regime and influencing factors in patients with tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004
The risk of ineffective MDR/XDR TB treatment, based on bedaquilin: factors and their influence Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Chemotherapy and tuberculosis as risk factors of urolithiasis Source: Eur Respir J 2005; 26: Suppl. 49, 688s Year: 2005
Effect of the risk factors on the characteristics of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008
Risk Factors for tuberculosis in patients on anti-TNF treatment Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Risk factors for anti-tuberculosis treatment failure Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011
Influence of social adaptation of tuberculosis patients on the TB form and a chemotherapy outcomes Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012
Factors influencing initial treatment effect and outcome of pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 478s Year: 2002
Risk factors associated with death in pulmonary tuberculosis Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009
Outcome of multidrug resistant tuberculosis (MDR-TB) treatment with possible influencing factors Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Risk factors for radiological and functional sequelae in multi-drug resistant tuberculosis Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Diseases and their treatment as risk factors for tuberculosis Source: Annual Congress 2004 - Risks for tuberculosis Year: 2004
Risk factors for drug-resistant tuberculosis patients in Lithuania, 2002–2008 Source: Eur Respir J 2012; 39: 1266-1269 Year: 2012
Factors associated with completion of tuberculosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 428s Year: 2005
Risk factors of development of amplified Mtb resistance to antituberculous drugs Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005
Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016